Acknowledgements I would like to thank my former PhD students and post-docs Anne Raben, Anne Flint, Camilla Verdich, Birgitte Sloth, Helle Harder, Anita Belza and Thomas Meinert Larsen for their invaluable contributions to the research described in this article
One is a gentle recalibration, the other is a structured medical intervention
Learn what the evidence says, the risks involved, and why clinicians advise caution
By Q2 2024, process engineers from Lillys existing sites were embedded in the new sites team, preparing run protocols
[9] While both medications are highly effective, the dual-action mechanism of tirzepatide may offer an additional advantage in weight reduction for some patients
In some healthcare systems, there could be limitations due to pricing and reimbursement considerations